Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
QNRX
QNRX | US
8.43
USD-0.24
-2.77%
QNRX | US
Loading StockChartView...
About QNRX
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
8.43
Open
8.67
High
9.01
Low
8.40
Quoin Pharmaceuticals Ltd. a clinical stage specialty pharmaceutical company focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003 a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn Virginia.
View LessQNRX | US
Risk
65.3
Sharpe
-0.13
Luna's Score
39/100
Recommendation
Sell
Luna says (QNRX | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
51.7%1 month
65.3%3 months
113.2%6 months
259.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.45
Debt to equity
0.43
Debt to assets
0.23
Ent. to EBITDA
-0.42
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-8.84M
MarketCap
33.55M
MarketCap(USD)
33.55M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-100.03
Short ratio
0.01
Short perc.
0.38
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.95
Range1M
3.44
Range3M
8.45
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.49
Price X volume
104.91K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.42 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.45 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 113.24 | 72.80 | Riskier |
| Debt to Equity | 0.43 | -1.23 | Expensive |
| Debt to Assets | 0.23 | 0.25 | Par |
| Market Cap | 33.55M | 3.66B | Emerging |
